Photo by nci from unsplash
Positron emission tomography‐computed tomography (PET‐CT) using prostate‐specific membrane antigen (PSMA) ligands is a method for imaging prostate cancer. A recent tracer, 18F‐PSMA‐1007, offers advantages concerning production and biokinetics compared to… Click to show full abstract
Positron emission tomography‐computed tomography (PET‐CT) using prostate‐specific membrane antigen (PSMA) ligands is a method for imaging prostate cancer. A recent tracer, 18F‐PSMA‐1007, offers advantages concerning production and biokinetics compared to the standard tracer (68Ga‐PSMA‐11). Until now, radiation dosimetry data for this ligand was limited to the material of three healthy volunteers. The purpose of this study is to study the biokinetics and dosimetry of 18F‐PSMA‐1007.
Journal Title: Clinical Physiology and Functional Imaging
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!